Previous 10 | Next 10 |
2024-03-13 14:01:40 ET More on Qiagen, Bio-Techne, etc. Qiagen N.V. 2023 Q4 - Results - Earnings Call Presentation Qiagen N.V. (QGEN) Q4 2023 Earnings Call Transcript Bio-Techne Corporation (TECH) Q2 2024 Earnings Call Transcript Qiagen upgraded at Morgan Sta...
2024-03-11 00:59:00 ET Even companies with solid prospects sometimes fail to keep pace with the market. When that happens, it's fair to give them a closer look. In some cases, an investment could pay off handsomely in the long run, provided the companies in question have excellent prospects...
In collaboration with The Blue Hat Foundation, “Box Out Colon Cancer” offers a timely spotlight on screening and prevention for the nation’s #2 cancer-related killer 1 Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tes...
2024-03-04 10:38:24 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips The seven stable stocks discussed below each have the potential to double by 2025 based on analyst target prices. Each of the seven stocks is also relatively stable based on the fact that none ...
2024-03-03 10:32:48 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Underdogs stocks carry almost universal appeal. It’s one thing to go with the rest of the crowd. It’s quite another to take your time to find some diamonds in the rough that could...
2024-03-01 18:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 3.3% to $4.09 on volume of 136,598,120 shares Nikola Corporation (NKLA) rose 8.9% to $0.7643 on volume of 134,299,966 shares Rivian Automotive Inc. (RIVN) fell 12.1% to $10.07 on...
Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conference and invited investors to participate by webcast. TD Cowen 44 th Annual Health Care Conference, Boston ...
2024-02-21 16:16:57 ET More on Exact Sciences Exact Sciences: Growing Revenue With An Innovative Approach To Oncology Exact Sciences Q4 2023 Earnings Preview Exact Sciences preliminary Q4 revenue beats Street estimates; CFO to step down Seeking Alpha’s...
Reports record revenue, generates positive free cash flow, expects 2024 revenue of $2.810-2.850 billion Fourth quarter and 2023 highlights Total fourth quarter revenue of $647 million, an increase of 17%, or 18% on a core revenue basis, with Screening revenue of $487 million and Pre...
News, Short Squeeze, Breakout and More Instantly...
Exact Sciences Corporation Company Name:
EXAS Stock Symbol:
NASDAQ Market:
Exact Sciences Corporation Website:
2024-07-11 08:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-08 08:30:00 ET To say that Exact Sciences (NASDAQ: EXAS) hasn't performed well on the stock market this year would be an understatement. Shares of the cancer-focused biotech are down by 41%. However, the healthcare company still has some fans on Wall Street. Cathie Wood ...
Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company plans to release its second quarter 2024 financial results after the close of the U.S. financial markets on July 31, 2024. Following the release, company management w...